SUTENT is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by U.s. Pharmaceuticals. The primary component is Sunitinib Malate.
| Product ID | 63539-017_23a46318-098e-48f1-a0cf-413d6a546c73 |
| NDC | 63539-017 |
| Product Type | Human Prescription Drug |
| Proprietary Name | SUTENT |
| Generic Name | Sunitinib Malate |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2006-01-26 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021938 |
| Labeler Name | U.S. Pharmaceuticals |
| Substance Name | SUNITINIB MALATE |
| Active Ingredient Strength | 13 mg/1 |
| Pharm Classes | Protein Kinase Inhibitors [MoA],Kinase Inhibitor [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2018-06-05 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0069-0550 | SUTENT | Sunitinib malate |
| 0069-0770 | SUTENT | Sunitinib malate |
| 0069-0830 | SUTENT | Sunitinib malate |
| 0069-0980 | SUTENT | Sunitinib malate |
| 63539-017 | SUTENT | SUTENT |
| 63539-019 | SUTENT | SUTENT |
| 0093-8199 | Sunitinib Malate | Sunitinib Malate |
| 0093-8224 | Sunitinib Malate | Sunitinib Malate |
| 0093-8229 | Sunitinib Malate | Sunitinib Malate |
| 0093-8231 | Sunitinib Malate | Sunitinib Malate |
| 0378-6678 | Sunitinib Malate | sunitinib malate |
| 0378-6679 | Sunitinib Malate | sunitinib malate |
| 0378-6680 | Sunitinib Malate | sunitinib malate |
| 0378-6681 | Sunitinib Malate | sunitinib malate |
| 16714-676 | Sunitinib malate | Sunitinib malate |
| 16714-677 | Sunitinib malate | Sunitinib malate |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() SUTENT 78750554 3170173 Live/Registered |
C.P. PHARMACEUTICALS INTERNATIONAL C.V. 2005-11-09 |
![]() SUTENT 78639799 not registered Dead/Abandoned |
Pharmacia & Upjohn Company LLC 2005-05-31 |
![]() SUTENT 76388649 2948764 Live/Registered |
C.P. PHARMACEUTICALS INTERNATIONAL C.V. 2002-03-26 |